Early Warning System for Allergic Rhinitis in the MASK-air® App

Launched by UNIVERSIDADE DO PORTO · Jan 6, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help people with allergic rhinitis, which is a condition that causes sneezing, a runny nose, and itchy eyes, especially during pollen season. The researchers want to see if using personalized messages that predict symptoms can help patients manage their condition better compared to standard messages already provided by the MASK-air® app. They will compare how well patients feel and how much medication they need to take when using these different types of messages.

To participate in this trial, you need to be an adult (18 years or older) who has been diagnosed with allergic rhinitis related to pollen allergies. Unfortunately, if you don't have a smartphone or can't complete a daily questionnaire about your symptoms, you won't be able to join. If you do participate, you can expect to receive messages that will help you track your symptoms and medication use over time. This study is not yet recruiting participants, but it aims to improve support for those living with allergic rhinitis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Adult patients (≥18 years old) of both sexes with clinical diagnosis of allergic rhinitis according to ARIA associated with pollen allergy.
• Exclusion Criteria:
• • Illiterate patients
• • Patients without smartphone
• • Patients who are not able to complete a daily monitoring questionnaire on allergic rhinitis.